Search results :

Nelfinavir

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: J05AE04

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8
Diarrhoea postmarketing — 0% - 38.5% 3% x x x x x x x x
Alanine aminotransferase increased common x
Nausea common, 0% - 7% 4% x x x x x x x x
Flatulence common, 0% - 5% 0% x x x x x x x x
Rash postmarketing — 0% - 8% 1% x x x x x x x x
Abdominal pain postmarketing x x x x x x x
Bronchospasm postmarketing x x x x x x x x
Oedema postmarketing x x x x x x x x
Body temperature increased postmarketing, 0% - 2.56% x x x x x x x x
Hyperbilirubinaemia postmarketing x x x x x x x
Hypersensitivity postmarketing x x x x x x x x
Jaundice postmarketing x x x x x x x x
Leukopenia postmarketing, 0% - 5.13% x x x x x x x x
Neutropenia postmarketing x x x x x x
Torsade de pointes postmarketing x x x x x x
Metabolic acidosis postmarketing x x x x x x x
Electrocardiogram QT corrected interval prolonged postmarketing x x x x x
Abdominal distension x
Anaemia 0% - 2.56% x x x x x x x x
Anorexia postmarketing, 0% - 4% x x x x x x x
Anxiety x x x x x x x
Arthralgia x x x x x x x
Arthritis x x x x x x x
Asthenia x x x x x x x
Back pain x x x x x x x
Connective tissue disorder x
Dehydration x x x x x x x
Dermatitis x x x x x x x
Fungal skin infection x x x x x x x
Diabetes mellitus x
Dizziness x x x x x x x
Dyspepsia x x x x x x x
Dyspnoea x x x x x x x
Epistaxis 0% - 2.56% x
Erythema multiforme x
Eye disorder x x x x x x x
Folliculitis x x x x x x x
Gastrointestinal disorder x
Gastrointestinal haemorrhage x x x x x x x
Headache x x x x x x x
Haemorrhage x
Hepatitis x x x x x x x x
Hyperglycaemia x x x x x x x x
Hyperlipidaemia x x x x x x x
Hypertriglyceridaemia x
Hypertrophy of breast x
Hypoglycaemia x x x x x x x
Immune system disorder x
Inflammation x
Insulin resistance x
Iritis x x x x x x x
Calculus of kidney x x x x x x x
Lipodystrophy x
Cramp muscle x x x x x x x
Myopathy x x x x x x x
Myositis x
Opportunistic infection x
Pain 0% - 5.13% x x x x x x x
Pancreatitis x x x x x x x x
Paraesthesia x x x x x x x
Pharyngitis x x x x x x x
Pneumonia x
Pruritus x x x x x x x x
Rhabdomyolysis x
Rhinitis x x x x x x x
Convulsion x x x x x x x
Sinusitis x x x x x x x
Suicide x x x x x x x
Sweating x x x x x x x
Thrombocytopenia x x x x x x x
Erythema x
Urticaria x x x x x x x
Angiopathy x
Vomiting x x x x x x x x
Mood swings x x x x x x x
Dermatitis bullous x
Mouth ulceration x x x x x x x
Migraine x x x x x x x
Accidental injury x x x x x x x
Liver function test abnormal x x x x x x x
Aspartate aminotransferase increased x
Haemoglobin decreased x
Malnutrition x
Unspecified disorder of skin and subcutaneous tissue x
Malaise x x x x x x x
Myalgia x x x x x x x x
Epigastric pain x x x x x x x
Urine abnormality x x x x x x x
Hepatic enzyme increased x
Hepatobiliary disease x
Rash maculo-papular x x x x x x x x
Hyperkinesia x x x x x x x
Buffalo hump x
Sexual dysfunction x x x x x x x
Blood cholesterol increased x
Hyperuricaemia x x x x x x x
Hyperlactacidaemia x
Sleep disorder x x x x x x x
Blood amylase increased x
Blood creatine phosphokinase increased x
Fat redistribution x x x x
Insomnia x x x x x x x
Myasthenia x x x x x x x
Lipohypertrophy x
Somnolence x x x x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

nelfinavir / nelfinavir

Side effects:49
Source:EMA

nelfinavir mesylate / VIRACEPT

Side effects:69
Source:FDA

NELFINAVIR MESYLATE / VIRACEPT

Side effects:71
Source:FDA

NELFINAVIR

Side effects:71
Source:FDA Structured Product Label

NELFINAVIR

Side effects:71
Source:FDA Structured Product Label

NELFINAVIR

Side effects:72
Source:FDA Structured Product Label

NELFINAVIR MESYLATE / VIRACEPT

Side effects:72
Source:FDA

NELFINAVIR (NELFINAVIR MESYLATE) / VIRACEPT

Side effects:73
Source:Health Canada

Color scheme:

standardalternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label